Relapsed leukemia flies under immune system’s radar | The Source | Washington University in St. Louis
School of Medicine research offers a potential explanation for why many patients with acute myeloid leukemia experience a relapse after a stem-cell transplant and suggests a therapeutic approach that may help to place relapsed patients back into remission.